Transforming cervical cancer screening in Namibia: The power of HPV DNA testing
From left to right. Front row: 1. Ben Nangombe, Executive Director in the Ministry of Health and Social Services, 2. First Lady of Namibia, Her Excellency Monica Geingos, 3. Merilynn Steenkamp, General Manager, Roche Diagnostics, 4. Rolf Hansen, CEO of the Cancer Association of Namibia Back row: 1. Jonathan Keytel, Director: Strategy and Transformation Africa, Roche Diagnostics, 2. Dr. Chris Maske, Qlab Inc. ● Roche hosts HPV Workshop in the fight against cervical cancer in Namibia ● Driving access to early screening and detection is critical in reaching WHO 90-70-90 goals ● Self-sampling technology is poised to transform cervical cancer prevention Roche Diagnostics recently hosted a Human Papillomavirus (HPV) Workshop to discuss Namibia’s cervical cancer elimination strategy. The discussion - focused on fostering collaboration with key stakeholders across the healthcare ecosystem to propel the country forward in eliminating cervical cancer by 2030 - included Her Excellenc